{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:19:54Z","timestamp":1790367594373,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s40266-019-00662-z","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T06:27:30Z","timestamp":1557383250000},"page":"65-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6992-6712","authenticated-orcid":false,"given":"Germain","family":"Honvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-752X","authenticated-orcid":false,"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rabenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Geerinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouafa","family":"Mkinsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-9393","authenticated-orcid":false,"given":"Olivier","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"issue":"9783","key":"662_CR1","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377(9783):2115\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(11)60243-2 .","journal-title":"Lancet"},{"issue":"11","key":"662_CR2","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.joca.2011.08.009","volume":"19","author":"D Pereira","year":"2011","unstructured":"Pereira D, Peleteiro B, Araujo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage. 2011;19(11):1270\u201385. https:\/\/doi.org\/10.1016\/j.joca.2011.08.009 .","journal-title":"Osteoarthritis Cartilage"},{"issue":"9859","key":"662_CR3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163\u201396. https:\/\/doi.org\/10.1016\/s0140-6736(12)61729-2 .","journal-title":"Lancet"},{"issue":"3","key":"662_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semarthrit.2014.05.014","volume":"44","author":"O Bruyere","year":"2014","unstructured":"Bruyere O, Cooper C, Pelletier JP, Branco J, Brandi ML, Guillemin F, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44(3):253\u201363. https:\/\/doi.org\/10.1016\/j.semarthrit.2014.05.014 .","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"662_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.joca.2009.10.006","volume":"18","author":"EM Bartels","year":"2010","unstructured":"Bartels EM, Bliddal H, Schondorff PK, Altman RD, Zhang W, Christensen R. Symptomatic efficacy and safety of diacerein in the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis Cartilage. 2010;18(3):289\u201396. https:\/\/doi.org\/10.1016\/j.joca.2009.10.006 .","journal-title":"Osteoarthritis Cartilage"},{"key":"662_CR6","doi-asserted-by":"publisher","unstructured":"Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2009(2):CD002946. https:\/\/doi.org\/10.1002\/14651858.cd002946.pub2 .","DOI":"10.1002\/14651858.cd002946.pub2"},{"key":"662_CR7","doi-asserted-by":"publisher","unstructured":"Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;1:CD005614. https:\/\/doi.org\/10.1002\/14651858.cd005614.pub2 .","DOI":"10.1002\/14651858.cd005614.pub2"},{"issue":"7","key":"662_CR8","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/art.22852","volume":"56","author":"JY Reginster","year":"2007","unstructured":"Reginster JY. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis Rheum. 2007;56(7):2105\u201310. https:\/\/doi.org\/10.1002\/art.22852 .","journal-title":"Arthritis Rheum"},{"issue":"12","key":"662_CR9","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/acr.22376","volume":"66","author":"P Eriksen","year":"2014","unstructured":"Eriksen P, Bartels EM, Altman RD, Bliddal H, Juhl C, Christensen R. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken). 2014;66(12):1844\u201355. https:\/\/doi.org\/10.1002\/acr.22376 .","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"Suppl 1","key":"662_CR10","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.joca.2010.02.016","volume":"18","author":"MC Hochberg","year":"2010","unstructured":"Hochberg MC. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage. 2010;18(Suppl 1):S28\u201331. https:\/\/doi.org\/10.1016\/j.joca.2010.02.016 .","journal-title":"Osteoarthritis Cartilage"},{"issue":"3","key":"662_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","volume":"22","author":"TE McAlindon","year":"2014","unstructured":"McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363\u201388. https:\/\/doi.org\/10.1016\/j.joca.2014.01.003 .","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"662_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465\u201374. https:\/\/doi.org\/10.1002\/acr.21596 .","journal-title":"Arthritis Care Res"},{"issue":"12","key":"662_CR13","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"KM Jordan","year":"2003","unstructured":"Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JWJ, Dieppe P, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145\u201355. https:\/\/doi.org\/10.1136\/ard.2003.011742 .","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"662_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1185\/03007995.2015.1027183","volume":"31","author":"JY Reginster","year":"2015","unstructured":"Reginster JY, Cooper C, Hochberg M, Pelletier JP, Rizzoli R, Kanis J, et al. Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis. Curr Med Res Opin. 2015;31(5):1041\u20135. https:\/\/doi.org\/10.1185\/03007995.2015.1027183 .","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"662_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40520-017-0861-1","volume":"30","author":"O Bruyere","year":"2017","unstructured":"Bruyere O, Cooper C, Al-Daghri NM, Dennison EM, Rizzoli R, Reginster JY. Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clin Exp Res. 2017;30(2):111\u20137. https:\/\/doi.org\/10.1007\/s40520-017-0861-1 .","journal-title":"Aging Clin Exp Res"},{"issue":"4","key":"662_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40520-018-0911-3","volume":"30","author":"JP Pelletier","year":"2018","unstructured":"Pelletier JP, Martel-Pelletier J. Diacerein-containing products: same risk of diarrhoea? Aging Clin Exp Res. 2018;30(4):411\u20132. https:\/\/doi.org\/10.1007\/s40520-018-0911-3 .","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"662_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/rheumatology\/ket463","volume":"53","author":"SR Kingsbury","year":"2014","unstructured":"Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford). 2014;53(5):937\u201347. https:\/\/doi.org\/10.1093\/rheumatology\/ket463 .","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"662_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/rheumatology\/keu403","volume":"54","author":"N Wilson","year":"2015","unstructured":"Wilson N, Sanchez-Riera L, Morros R, Diez-Perez A, Javaid MK, Cooper C, et al. Drug utilization in patients with OA: a population-based study. Rheumatology (Oxford). 2015;54(5):860\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/keu403 .","journal-title":"Rheumatology (Oxford)"},{"key":"662_CR19","doi-asserted-by":"publisher","unstructured":"Pavelka K, Bruyere O, Cooper C, Kanis JA, Leeb BF, Maheu E et al. Diacerein: Benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs Aging. 2016;33(2):75\u201385. https:\/\/doi.org\/10.1007\/s40266-016-0347-4 .","DOI":"10.1007\/s40266-016-0347-4"},{"key":"662_CR20","doi-asserted-by":"publisher","unstructured":"Fidelix TS, Macedo CR, Maxwell LJ, Fernandes Moca Trevisani V. Diacerein for osteoarthritis. Cochrane Database Syst Rev. 2014;2:CD005117. https:\/\/doi.org\/10.1002\/14651858.cd005117.pub3 .","DOI":"10.1002\/14651858.cd005117.pub3"},{"key":"662_CR21","doi-asserted-by":"publisher","first-page":"c4675","DOI":"10.1136\/bmj.c4675","volume":"341","author":"S Wandel","year":"2010","unstructured":"Wandel S, Juni P, Tendal B, Nuesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ. 2010;341:c4675. https:\/\/doi.org\/10.1136\/bmj.c4675 .","journal-title":"BMJ"},{"key":"662_CR22","doi-asserted-by":"publisher","unstructured":"Cameron M, Chrubasik S. Oral herbal therapies for treating osteoarthritis. Cochrane Database Syst Rev. 2014(5):CD002947. https:\/\/doi.org\/10.1002\/14651858.cd002947.pub2 .","DOI":"10.1002\/14651858.cd002947.pub2"},{"key":"662_CR23","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 (updated March 2011). Available from: www.handbook.cochrane.org . The Cochrane Collaboration; 2011. Accessed 22 May 2017."},{"issue":"10","key":"662_CR24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.005 .","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"662_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"1","key":"662_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53\u201377. https:\/\/doi.org\/10.1002\/sim.2528 .","journal-title":"Stat Med"},{"issue":"29","key":"662_CR27","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/sim.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046\u201367. https:\/\/doi.org\/10.1002\/sim.4040 .","journal-title":"Stat Med"},{"issue":"3","key":"662_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P","volume":"18","author":"SL Normand","year":"1999","unstructured":"Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18(3):321\u201359.","journal-title":"Stat Med"},{"issue":"7414","key":"662_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557 .","journal-title":"BMJ"},{"issue":"11","key":"662_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358. https:\/\/doi.org\/10.1002\/sim.1186 .","journal-title":"Stat Med"},{"issue":"20","key":"662_CR31","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1002\/sim.2380","volume":"25","author":"RM Harbord","year":"2006","unstructured":"Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443\u201357. https:\/\/doi.org\/10.1002\/sim.2380 .","journal-title":"Stat Med"},{"key":"662_CR32","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. https:\/\/doi.org\/10.1136\/bmj.d4002 .","journal-title":"BMJ"},{"issue":"7109","key":"662_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"662_CR34","doi-asserted-by":"publisher","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026 .","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"662_CR35","unstructured":"GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from gradepro.org.: Evidence Prime, Inc."},{"key":"662_CR36","unstructured":"Benito-Ruiz P, Camacho-Zambrano MM, Carrillo-Arcentales JN, Mestanza-Peralta MA, Vallejo-Flores CA, Vargas-Lopez SV et al. A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort. International journal of food sciences and nutrition. 2009;60 Suppl 2(ccg, 9432922):99\u2013113."},{"key":"662_CR37","unstructured":"Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis and Cartilage. 1998;6 Suppl A(9305697, cco):31\u20136."},{"issue":"6","key":"662_CR38","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.tripleo.2011.06.012","volume":"112","author":"BJ Cahlin","year":"2011","unstructured":"Cahlin BJ, Dahlstrom L. No effect of glucosamine sulfate on osteoarthritis in the temporomandibular joints\u2014a randomized, controlled, short-term study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(6):760\u20136.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"101215021","key":"662_CR39","doi-asserted-by":"crossref","first-page":"724291","DOI":"10.1155\/2011\/724291","volume":"2011","author":"A Chopra","year":"2011","unstructured":"Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukaddam S, Raut AK, et al. A randomized controlled exploratory evaluation of standardized ayurvedic formulations in symptomatic osteoarthritis knees: a Government of India NMITLI Project. Evid-based Complementary Altern Med. 2011;2011(101215021):724291.","journal-title":"Evid-based Complementary Altern Med"},{"issue":"8","key":"662_CR40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa052771","volume":"354","author":"DO Clegg","year":"2006","unstructured":"Clegg DO, Reda DJ, Harris CL, Klein MA, O\u2019Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa052771 .","journal-title":"N Engl J Med"},{"issue":"3","key":"662_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/eye.2016.221","volume":"31","author":"H Esfandiari","year":"2017","unstructured":"Esfandiari H, Pakravan M, Zakeri Z, Ziaie S, Pakravan P, Ownagh V. Effect of glucosamine on intraocular pressure: a randomized clinical trial. Eye (London, England). 2017;31(3):389\u201394.","journal-title":"Eye (London, England)."},{"issue":"101152213","key":"662_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2891-7-9","volume":"7","author":"JL Frestedt","year":"2008","unstructured":"Frestedt JL, Walsh M, Kuskowski MA, Zenk JL. A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. Nutr J. 2008;7(101152213):9.","journal-title":"Nutr J"},{"issue":"11","key":"662_CR43","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1002\/art.30574","volume":"63","author":"C Gabay","year":"2011","unstructured":"Gabay C, Medinger-Sadowski C, Gascon D, Kolo F, Finckh A. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center. Arthritis Rheum. 2011;63(11):3383\u201391.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"662_CR44","first-page":"19","volume":"25","author":"JX Jiang","year":"2014","unstructured":"Jiang JX, Yu S, Huang QR, Zhang XL, Zhang CQ, Zhou JL, et al. Collagen peptides improve knee osteoarthritis in elderly women: a 6-month randomized, double-blind, placebo-controlled study. Agro Food Industry Hi-Tech. 2014;25(2):19\u201323.","journal-title":"Agro Food Industry Hi-Tech."},{"issue":"101152213","key":"662_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2891-7-3","volume":"7","author":"DS Kalman","year":"2008","unstructured":"Kalman DS, Heimer M, Valdeon A, Schwartz H, Sheldon E. Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial. Nutr J. 2008;7(101152213):3.","journal-title":"Nutr J"},{"issue":"4","key":"662_CR46","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/art.38314","volume":"66","author":"CK Kwoh","year":"2014","unstructured":"Kwoh CK, Roemer FW, Hannon MJ, Moore CE, Jakicic JM, Guermazi A, et al. Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial. Arthritis Rheumatol. 2014;66(4):930\u20139.","journal-title":"Arthritis Rheumatol."},{"issue":"101152213","key":"662_CR47","first-page":"14","volume":"15","author":"JP Lugo","year":"2016","unstructured":"Lugo JP, Saiyed ZM, Lane NE. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutr J. 2016;15(101152213):14.","journal-title":"Nutr J"},{"key":"662_CR48","unstructured":"Moller I, Perez M, Monfort J, Benito P, Cuevas J, Perna C et al. Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. Osteoarthr Cartilage. 2010;18 Suppl 1(9305697, cco):S32\u201340."},{"issue":"1","key":"662_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1063-4584(05)80006-8","volume":"2","author":"W Noack","year":"1994","unstructured":"Noack W, Fischer M, Forster KK, Rovati LC, Setnikar I. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthr Cartilage. 1994;2(1):51\u20139.","journal-title":"Osteoarthr Cartilage."},{"issue":"18","key":"662_CR50","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1001\/archinte.162.18.2113","volume":"162","author":"K Pavelka","year":"2002","unstructured":"Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162(18):2113\u201323.","journal-title":"Arch Intern Med"},{"issue":"12","key":"662_CR51","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1002\/art.23056","volume":"56","author":"K Pavelka","year":"2007","unstructured":"Pavelka K, Trc T, Karpas K, Vitek P, Sedlackova M, Vlasakova V, et al. The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period. Arthritis Rheum. 2007;56(12):4055\u201364.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"662_CR52","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P","volume":"43","author":"JP Pelletier","year":"2000","unstructured":"Pelletier JP, Yaron M, Haraoui B, Cohen P, Nahir MA, Choquette D, et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. Arthritis Rheum. 2000;43(10):2339\u201348.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"662_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1185\/03007998009112036","volume":"7","author":"JM Pujalte","year":"1980","unstructured":"Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin. 1980;7(2):110\u20134.","journal-title":"Curr Med Res Opin"},{"key":"662_CR54","doi-asserted-by":"publisher","unstructured":"Reginster JL, Group CI. CONCEPT provides robust evidence that chondroitin sulfate is superior to placebo and similar to celecoxib in the symptomatic management of osteoarthritis. Ann Rheum Dis. 2017. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212165 .","DOI":"10.1136\/annrheumdis-2017-212165"},{"key":"662_CR55","doi-asserted-by":"publisher","unstructured":"Roman-Blas JA, Castaneda S, Sanchez-Pernaute O, Largo R, Herrero-Beaumont G, Group CGCTS. Combined treatment with chondroitin sulfate and glucosamine sulfate shows no superiority over placebo for reduction of joint pain and functional impairment in patients with knee osteoarthritis: a six-month multicenter, randomized, double-blind, placebo-controlled clinical trial. Arthritis Rheumatol. 2017;69(1):77\u201385. https:\/\/doi.org\/10.1002\/art.39819 .","DOI":"10.1002\/art.39819"},{"issue":"16","key":"662_CR56","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1021\/jf205295u","volume":"60","author":"AG Schauss","year":"2012","unstructured":"Schauss AG, Stenehjem J, Park J, Endres JR, Clewell A. Effect of the novel low molecular weight hydrolyzed chicken sternal cartilage extract, BioCell Collagen, on improving osteoarthritis-related symptoms: a randomized, double-blind, placebo-controlled trial. J Agric Food Chem. 2012;60(16):4096\u2013101.","journal-title":"J Agric Food Chem"},{"key":"662_CR57","unstructured":"Uebelhart D, Thonar EJ, Delmas PD, Chantraine A, Vignon E. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthr Cartilage. 1998;6 Suppl A(9305697, cco):39\u201346."},{"issue":"4","key":"662_CR58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","volume":"12","author":"D Uebelhart","year":"2004","unstructured":"Uebelhart D, Malaise M, Marcolongo R, de Vathaire F, Piperno M, Mailleux E, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthr Cartilage. 2004;12(4):269\u201376.","journal-title":"Osteoarthr Cartilage."},{"issue":"6","key":"662_CR59","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00044011-200424060-00005","volume":"24","author":"PR Usha","year":"2004","unstructured":"Usha PR, Naidu MUR. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig. 2004;24(6):353\u201363.","journal-title":"Clin Drug Investig."},{"key":"662_CR60","doi-asserted-by":"publisher","unstructured":"Zegels B, Crozes P, Uebelhart D, Bruyere O, Reginster JY. Equivalence of a single dose (1200\u00a0mg) compared to a three-time a day dose (400\u00a0mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study. Osteoarthr Cartilage. 2013;21(1):22\u20137. https:\/\/doi.org\/10.1016\/j.joca.2012.09.017 .","DOI":"10.1016\/j.joca.2012.09.017"},{"key":"662_CR61","unstructured":"Appelboom T, Schuermans J, Verbruggen G, Henrotin Y, Reginster JY. Symptoms modifying effect of avocado\/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scand J Rheumatol. 2001;30(4):242\u20137."},{"key":"662_CR62","unstructured":"Blotman F, Maheu E, Wulwik A, Caspard H, Lopez A. Efficacy and safety of avocado\/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rheum Engl Ed. 1997;64(12):825\u201334."},{"key":"662_CR63","unstructured":"Bourgeois P, Chales G, Dehais J, Delcambre B, Kuntz JL, Rozenberg S. Efficacy and tolerability of chondroitin sulfate 1200\u00a0mg\/day vs. chondroitin sulfate 3 x 400\u00a0mg\/day vs. placebo. Osteoarthritis and Cartilage. 1998;6 Suppl A(9305697, cco):25\u201330."},{"issue":"5","key":"662_CR64","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/art.20697","volume":"51","author":"J Cibere","year":"2004","unstructured":"Cibere J, Kopec JA, Thorne A, Singer J, Canvin J, Robinson DB, et al. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum. 2004;51(5):738\u201345.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"662_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/joca.1999.0308","volume":"8","author":"A Das Jr","year":"2000","unstructured":"Das A Jr, Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthr Cartilage. 2000;8(5):343\u201350.","journal-title":"Osteoarthr Cartilage."},{"key":"662_CR66","doi-asserted-by":"crossref","unstructured":"Dougados M, Nguyen M, Berdah L, Mazieres B, Vignon E, Lequesne M. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum. 2001;44(11):2539\u201347.","DOI":"10.1002\/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T"},{"issue":"4","key":"662_CR67","first-page":"260","volume":"3","author":"A Drovanti","year":"1980","unstructured":"Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther. 1980;3(4):260\u201372.","journal-title":"Clin Ther"},{"issue":"5","key":"662_CR68","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1136\/annrheumdis-2013-203954","volume":"74","author":"M Fransen","year":"2015","unstructured":"Fransen M, Agaliotis M, Nairn L, Votrubec M, Bridgett L, Su S, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis. 2015;74(5):851\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203954 .","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"662_CR69","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.curtheres.2009.05.004","volume":"70","author":"N Giordano","year":"2009","unstructured":"Giordano N, Fioravanti A, Papakostas P, Montella A, Giorgi G, Nuti R. The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Curr Ther Res Clin Exp. 2009;70(3):185\u201396. https:\/\/doi.org\/10.1016\/j.curtheres.2009.05.004 .","journal-title":"Curr Ther Res Clin Exp."},{"issue":"2","key":"662_CR70","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/art.22371","volume":"56","author":"G Herrero-Beaumont","year":"2007","unstructured":"Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martin-Mola E, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56(2):555\u201367. https:\/\/doi.org\/10.1002\/art.22371 .","journal-title":"Arthritis Rheum"},{"issue":"3","key":"662_CR71","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/rheumatology\/41.3.279","volume":"41","author":"R Hughes","year":"2002","unstructured":"Hughes R, Carr A. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology (Oxford, England). 2002;41(3):279\u201384.","journal-title":"Rheumatology (Oxford, England)."},{"issue":"2","key":"662_CR72","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/art.24255","volume":"60","author":"A Kahan","year":"2009","unstructured":"Kahan A, Uebelhart D, De Vathaire F, Delmas PD, Reginster JY. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60(2):524\u201333. https:\/\/doi.org\/10.1002\/art.24255 .","journal-title":"Arthritis Rheum"},{"key":"662_CR73","doi-asserted-by":"publisher","unstructured":"Kumar S, Sugihara F, Suzuki K, Inoue N, Venkateswarathirukumara S. A double-blind, placebo-controlled, randomised, clinical study on the effectiveness of collagen peptide on osteoarthritis. J Sci Food Agric. 2014. https:\/\/doi.org\/10.1002\/jsfa.6752 .","DOI":"10.1002\/jsfa.6752"},{"issue":"17 Suppl","key":"662_CR74","first-page":"S31","volume":"48","author":"M Lequesne","year":"1998","unstructured":"Lequesne M, Berdah L, Gerentes I. Efficacy and tolerance of diacerhein in the treatment of gonarthrosis and coxarthrosis. La Revue du praticien. 1998;48(17 Suppl):S31\u20135.","journal-title":"La Revue du praticien."},{"issue":"1","key":"662_CR75","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/art1.10239","volume":"47","author":"M Lequesne","year":"2002","unstructured":"Lequesne M, Maheu E, Cadet C, Dreiser RL. Structural effect of avocado\/soybean unsaponifiables on joint space loss in osteoarthritis of the hip. Arthritis Rheum. 2002;47(1):50\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"662_CR76","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/1529-0131(199801)41:1<81::AID-ART11>3.0.CO;2-9","volume":"41","author":"E Maheu","year":"1998","unstructured":"Maheu E, Mazieres B, Valat JP, Loyau G, Le Loet X, Bourgeois P, et al. Symptomatic efficacy of avocado\/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum. 1998;41(1):81\u201391. https:\/\/doi.org\/10.1002\/1529-0131(199801)41:1%3c81:AID-ART11%3e3.0.CO;2-9 .","journal-title":"Arthritis Rheum"},{"issue":"2","key":"662_CR77","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/annrheumdis-2012-202485","volume":"73","author":"E Maheu","year":"2014","unstructured":"Maheu E, Cadet C, Marty M, Moyse D, Kerloch I, Coste P, et al. Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study. Ann Rheum Dis. 2014;73(2):376\u201384. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202485 .","journal-title":"Ann Rheum Dis"},{"issue":"29","key":"662_CR78","first-page":"1386","volume":"31","author":"P Mathieu","year":"2002","unstructured":"Mathieu P. Radiological progression of internal femorotibial osteoarthritis in gonarthrosis: effect of chondroitin sulfates ACS4-ACS6 as a structure modifying drug in knee OA (SMOAD). Presse Medicale. 2002;31(29):1386\u201390.","journal-title":"Presse Medicale."},{"key":"662_CR79","unstructured":"Mazieres B, Loyau G, Menkes CJ, Valat JP, Dreiser RL, Charlot J et al. [Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-months result of a multicenter double-blind controlled prospective study using placebo]. Rev Rhum Mal Osteoartic. 1992;59(7\u20138):466\u201372."},{"issue":"1","key":"662_CR80","first-page":"173","volume":"28","author":"B Mazieres","year":"2001","unstructured":"Mazieres B, Combe B, Van Phan A, Tondut J, Grynfeltt M. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. J Rheumatol. 2001;28(1):173\u201381.","journal-title":"J Rheumatol"},{"issue":"5","key":"662_CR81","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/ard.2006.059899","volume":"66","author":"B Mazieres","year":"2007","unstructured":"Mazieres B, Hucher M, Zaim M, Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis. 2007;66(5):639\u201345. https:\/\/doi.org\/10.1136\/ard.2006.059899 .","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"662_CR82","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.joca.2011.01.001","volume":"19","author":"TE McAlindon","year":"2011","unstructured":"McAlindon TE, Nuite M, Krishnan N, Ruthazer R, Price LL, Burstein D, et al. Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial. Osteoarthr Cartilage. 2011;19(4):399\u2013405.","journal-title":"Osteoarthr Cartilage."},{"issue":"3","key":"662_CR83","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/art.20867","volume":"52","author":"BA Michel","year":"2005","unstructured":"Michel BA, Stucki G, Frey D, De Vathaire F, Vignon E, Bruehlmann P, et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005;52(3):779\u201386. https:\/\/doi.org\/10.1002\/art.20867 .","journal-title":"Arthritis Rheum"},{"issue":"6","key":"662_CR84","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00776-014-0633-0","volume":"19","author":"Y Nakagawa","year":"2014","unstructured":"Nakagawa Y, Mukai S, Yamada S, Matsuoka M, Tarumi E, Hashimoto T, et al. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: a randomized, double-blind, placebo-controlled prospective study. J Orthopaedic Sci. 2014;19(6):933\u20139.","journal-title":"J Orthopaedic Sci."},{"issue":"4","key":"662_CR85","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/art.1780370413","volume":"37","author":"M Nguyen","year":"1994","unstructured":"Nguyen M, Dougados M, Berdah L, Amor B. Diacerein in the treatment of osteoarthritis of the hip. Arthritis Rheum. 1994;37(4):529\u201336.","journal-title":"Arthritis Rheum."},{"issue":"11","key":"662_CR86","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ptr.5174","volume":"28","author":"Y Panahi","year":"2014","unstructured":"Panahi Y, Rahimnia A-R, Sharafi M, Alishiri G, Saburi A, Sahebkar A. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytotherapy Res. 2014;28(11):1625\u201331.","journal-title":"Phytotherapy Res."},{"issue":"12","key":"662_CR87","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1136\/ard.2003.019703","volume":"63","author":"T Pham","year":"2004","unstructured":"Pham T, Le Henanff A, Ravaud P, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1\u00a0year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis. 2004;63(12):1611\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"662_CR88","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s10067-012-2022-4","volume":"31","author":"JJ Railhac","year":"2012","unstructured":"Railhac JJ, Zaim M, Saurel AS, Vial J, Fournie B. Effect of 12\u00a0months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI. Clin Rheumatol. 2012;31(9):1347\u201357.","journal-title":"Clin Rheumatol"},{"issue":"9252","key":"662_CR89","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","volume":"357","author":"JY Reginster","year":"2001","unstructured":"Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357(9252):251\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(00)03610-2 .","journal-title":"Lancet"},{"issue":"2","key":"662_CR90","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/ewjm.172.2.91","volume":"172","author":"JP Rindone","year":"2000","unstructured":"Rindone JP, Hiller D, Collacott E, Nordhaugen N, Arriola G. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med. 2000;172(2):91\u20134.","journal-title":"West J Med."},{"issue":"4","key":"662_CR91","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/0003-4819-148-4-200802190-00005","volume":"148","author":"RM Rozendaal","year":"2008","unstructured":"Rozendaal RM, Koes BW, van Osch GJVM, Uitterlinden EJ, Garling EH, Willemsen SP, et al. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med. 2008;148(4):268\u201377.","journal-title":"Ann Intern Med"},{"issue":"4","key":"662_CR92","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.clinthera.2013.02.009","volume":"35","author":"K Shin","year":"2013","unstructured":"Shin K, Kim JW, Moon KW, Yang JA, Lee EY, Song YW, et al. The efficacy of diacerein in hand osteoarthritis: a double-blind, randomized, placebo-controlled study. Clin Ther. 2013;35(4):431\u20139.","journal-title":"Clin Ther"},{"issue":"6","key":"662_CR93","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10787-016-0289-9","volume":"24","author":"S Srivastava","year":"2016","unstructured":"Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS. Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology. 2016;24(6):377\u201388.","journal-title":"Inflammopharmacology"},{"issue":"5","key":"662_CR94","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5114\/reum.2012.31397","volume":"50","author":"R Stan\u010d\u00edk","year":"2012","unstructured":"Stan\u010d\u00edk R, Zvarka J, Hlav\u00e1\u010d M, Kubinec V, Rovensk\u00fd J. Collagen type I in the treatment of painful osteoarthritis of the knee. Reumatologia. 2012;50(5):390\u20136. https:\/\/doi.org\/10.5114\/reum.2012.31397 .","journal-title":"Reumatologia."},{"key":"662_CR95","unstructured":"Vignon E. Results of ECHODIAH study in hip osteoarthritis. [French]. Resultats de l\u2019essai therapeutique ECHODIAH dans l\u2019arthrose de hanche. 2002;31(1 II):7."},{"issue":"6","key":"662_CR96","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/ard.2010.140848","volume":"70","author":"LM Wildi","year":"2011","unstructured":"Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6\u00a0months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis. 2011;70(6):982\u20139. https:\/\/doi.org\/10.1136\/ard.2010.140848 .","journal-title":"Ann Rheum Dis"},{"key":"662_CR97","doi-asserted-by":"crossref","unstructured":"Zenk Jl HTRKMA. The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: An exploratory, randomized, double-blind, placebo-controlled trial. 2002;63(7):430.","DOI":"10.1016\/S0011-393X(02)80049-2"},{"key":"662_CR98","doi-asserted-by":"publisher","first-page":"16827","DOI":"10.1038\/srep16827","volume":"5","author":"C Zeng","year":"2015","unstructured":"Zeng C, Wei J, Li H, Wang YL, Xie DX, Yang T, et al. Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. Sci Rep. 2015;5:16827. https:\/\/doi.org\/10.1038\/srep16827 .","journal-title":"Sci Rep."},{"issue":"1","key":"662_CR99","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1947603514554992","volume":"6","author":"BA Christiansen","year":"2015","unstructured":"Christiansen BA, Bhatti S, Goudarzi R, Emami S. Management of osteoarthritis with avocado\/soybean unsaponifiables. Cartilage. 2015;6(1):30\u201344. https:\/\/doi.org\/10.1177\/1947603514554992 .","journal-title":"Cartilage."},{"issue":"10","key":"662_CR100","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.joca.2008.02.017","volume":"16","author":"P Msika","year":"2008","unstructured":"Msika P, Baudouin C, Saunois A, Bauer T. Avocado\/soybean unsaponifiables, ASU EXPANSCIENCE, are strictly different from the nutraceutical products claiming ASU appellation. Osteoarthritis Cartilage. 2008;16(10):1275\u20136. https:\/\/doi.org\/10.1016\/j.joca.2008.02.017 .","journal-title":"Osteoarthritis Cartilage"},{"key":"662_CR101","doi-asserted-by":"publisher","unstructured":"Olivier P, Montastruc JL, Reseau francais des centres regionaux de p. [Post-marketing safety profile of avocado-soybean unsaponifiables]. Presse Med. 2010;39(10):e211\u20136. https:\/\/doi.org\/10.1016\/j.lpm.2010.01.013 .","DOI":"10.1016\/j.lpm.2010.01.013"},{"issue":"5","key":"662_CR102","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2165\/00003088-199835050-00002","volume":"35","author":"P Nicolas","year":"1998","unstructured":"Nicolas P, Tod M, Padoin C, Petitjean O. Clinical pharmacokinetics of diacerein. Clin Pharmacokinet. 1998;35(5):347\u201359. https:\/\/doi.org\/10.2165\/00003088-199835050-00002 .","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"662_CR103","first-page":"190","volume":"56","author":"X Renan","year":"2001","unstructured":"Renan X, Lepage M, Connan D, Carlhant D, Riche C, Verger P, et al. Case report of fatal hepatitis from diacerein. Therapie. 2001;56(2):190\u20131.","journal-title":"Therapie."},{"issue":"10","key":"662_CR104","first-page":"795","volume":"21","author":"T Vial","year":"1997","unstructured":"Vial T, Mille R, Bory RM, Evreux JC. Acute hepatitis asociated with ingestion of of diacerein. Gastroenterol Clin Biol. 1997;21(10):795\u20136.","journal-title":"Gastroenterol Clin Biol"},{"issue":"10","key":"662_CR105","first-page":"851","volume":"19","author":"H Blondon","year":"1995","unstructured":"Blondon H, Bikart I, Bergmann JF. Severe diarrhea with hypokalemia attributed to diacetylrhein. Gastroenterol Clin Biol. 1995;19(10):851\u20132.","journal-title":"Gastroenterol Clin Biol"},{"key":"662_CR106","unstructured":"EMA. European Medicines Agency. Assessment report for diacerein containing medicinal products. EMA\/527347\/2014. 2014. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Diacerein\/European_Commission_final_decision\/WC500173145.pdf . Accessed 27 Apr 2018."},{"issue":"10","key":"662_CR107","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2337\/dc17-0374","volume":"40","author":"CRL Cardoso","year":"2017","unstructured":"Cardoso CRL, Leite NC, Carlos FO, Loureiro AA, Viegas BB, Salles GF. Efficacy and safety of diacerein in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Care. 2017;40(10):1356\u201363. https:\/\/doi.org\/10.2337\/dc17-0374 .","journal-title":"Diabetes Care"},{"issue":"10","key":"662_CR108","doi-asserted-by":"publisher","first-page":"e0186554","DOI":"10.1371\/journal.pone.0186554","volume":"12","author":"F Piovesan","year":"2017","unstructured":"Piovesan F, Tres GS, Moreira LB, Andrades ME, Lisboa HK, Fuchs SC. Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: a randomized controlled trial. PLoS One. 2017;12(10):e0186554. https:\/\/doi.org\/10.1371\/journal.pone.0186554 .","journal-title":"PLoS One"},{"key":"662_CR109","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejphar.2018.07.031","volume":"834","author":"T Bu","year":"2018","unstructured":"Bu T, Wang C, Meng Q, Huo X, Sun H, Sun P, et al. Hepatoprotective effect of rhein against methotrexate-induced liver toxicity. Eur J Pharmacol. 2018;834:266\u201373. https:\/\/doi.org\/10.1016\/j.ejphar.2018.07.031 .","journal-title":"Eur J Pharmacol"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00662-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-019-00662-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-019-00662-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T16:32:11Z","timestamp":1721233931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-019-00662-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":109,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["662"],"URL":"https:\/\/doi.org\/10.1007\/s40266-019-00662-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"9 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors meet the ICMJE criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"G Honvo was funded by the ESCEO, a Belgian not-for-profit organization. The ESCEO Working Group was entirely funded by the ESCEO. The ESCEO receives unrestricted educational grants, to support its educational and scientific activities, from non-governmental organizations, not-for-profit organizations, non-commercial and corporate partners. The choice of topics, participants, content, and agenda of the working groups as well as the writing, editing, submission, and reviewing of the manuscript are under the sole responsibility of the ESCEO without any influence from third parties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"O Bruy\u00e8re has received grants from Biophytis, IBSA, MEDA, Servier, SMB, and Theramex, outside the submitted work. C. Cooper has received personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda, and UCB, outside of the submitted work. J-Y. Reginster has received grants from IBSA-Genevrier, Mylan, CNIEL, and Radius Health (through their institution); consulting fees from IBSA-Genevrier, Mylan, CNIEL, Radius Health, and Pierre Fabre; fees for participation in review activities from IBSA-Genevrier, MYLAN, CNIEL, Radius Health, and Teva; payment for lectures from AgNovos, CERIN, CNIEL, Dairy Research Council (DRC), Echolight, IBSA-Genevrier, Mylan, Pfizer Consumer Health, Teva, and Theramex, outside of the submitted work. B. Avouac has received consulting fees from Novartis, BMS, Roche, Janssen Cilag, Expanscience, and IRIS and fees for participating in research activities from Sanofi, Amgen, Takeda, Allegan, Abbvie, Vertex, AstraZeneca, Ipsen, Leadiant, Otsuka, Jazz, Leo, and alexion, outside of the submitted work. G. Honvo, R. Rizzoli, O. Mkinsi, A. Geerinck, A. Charles and V. Rabenda have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}